Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Gastroenterology
|
July 26, 2015
Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody
Øyvind Steinsbø, Siri Dørum, Knut E A Lundin, et al.
The American Journal of Gastroenterology
|
January 30, 2025
Fecal Calprotectin Correlates with Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis
Øyvind Steinsbø, Ole Gunnar Aasprong, Lars Aabakken, et al.
Scientific Reports
|
May 6, 2016
Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes
Siri Dørum, Øyvind Steinsbø, Elin Bergseng, et al.
Therapeutic Advances in Gastroenterology
|
December 12, 2022
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
Øyvind Steinsbø, Arne Carlsen, Ole Gunnar Aasprong, et al.
JCI Insight
|
September 8, 2017
Stereotyped antibody responses target posttranslationally modified gluten in celiac disease
Omri Snir, Xi Chen, Moriah Gidoni, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
June 10, 2020
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease
Arne Carlsen, Roald Omdal, Lars Karlsen, et al.
Scandinavian Journal of Immunology
|
April 28, 2025
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy
Tore Grimstad, Arne Carlsen, Jan Terje Kvaløy, et al.
Scandinavian Journal of Gastroenterology
|
October 17, 2025
Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease
Arne Carlsen, Øyvind Steinsbø, Jan Terje Kvaløy, et al.
Nature Communications
|
June 10, 2014
Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells
Øyvind Steinsbø, Carole J Henry Dunand, Min Huang, et al.
Cell Reports
|
September 7, 2017
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins
Rasmus Iversen, Omri Snir, Maria Stensland, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Gastroenterology
|
July 26, 2015
Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody
Øyvind Steinsbø, Siri Dørum, Knut E A Lundin, et al.
The American Journal of Gastroenterology
|
January 30, 2025
Fecal Calprotectin Correlates with Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis
Øyvind Steinsbø, Ole Gunnar Aasprong, Lars Aabakken, et al.
Scientific Reports
|
May 6, 2016
Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes
Siri Dørum, Øyvind Steinsbø, Elin Bergseng, et al.
Therapeutic Advances in Gastroenterology
|
December 12, 2022
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
Øyvind Steinsbø, Arne Carlsen, Ole Gunnar Aasprong, et al.
JCI Insight
|
September 8, 2017
Stereotyped antibody responses target posttranslationally modified gluten in celiac disease
Omri Snir, Xi Chen, Moriah Gidoni, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
June 10, 2020
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease
Arne Carlsen, Roald Omdal, Lars Karlsen, et al.
Scandinavian Journal of Immunology
|
April 28, 2025
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy
Tore Grimstad, Arne Carlsen, Jan Terje Kvaløy, et al.
Scandinavian Journal of Gastroenterology
|
October 17, 2025
Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease
Arne Carlsen, Øyvind Steinsbø, Jan Terje Kvaløy, et al.
Nature Communications
|
June 10, 2014
Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells
Øyvind Steinsbø, Carole J Henry Dunand, Min Huang, et al.
Cell Reports
|
September 7, 2017
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins
Rasmus Iversen, Omri Snir, Maria Stensland, et al.
Page
of 2